Altitude Sickness Prophylaxis
Acetazolamide 125-250 mg twice daily is the recommended prophylaxis for acute mountain sickness, with gradual ascent (not exceeding 300-500 m/day above 2500 m) being the most important preventive measure.
Primary Prophylactic Medication
Acetazolamide Dosing
- Acetazolamide 250 mg daily (125 mg twice daily) is the lowest effective dose for preventing acute mountain sickness above 3000 m, with a number needed to treat of 6 1
- Doses of 250 mg, 500 mg, and 750 mg daily are all more effective than placebo, but 250 mg represents the optimal balance of efficacy and tolerability 1
- Higher doses (750 mg daily) show efficacy with a number needed to treat of approximately 3, but acetazolamide 500 mg has not consistently demonstrated effectiveness 2
- The medication works by increasing ventilation at altitude through metabolic acidosis, producing increased alveolar oxygen tension 3
Clinical Benefits
- Acetazolamide reduces headache, nausea, drowsiness, shortness of breath, and dizziness while improving psychological well-being 3
- It lowers blood pressure at high altitude while improving oxygen saturation and mountain sickness symptoms 4
- In cardiovascular patients, acetazolamide may reduce the risk of subendocardial ischemia at high altitude, though data in coronary artery disease patients are limited 4
Non-Pharmacological Prevention
Ascent Strategy
- Gradual ascent is the single most important preventive measure 5, 6
- Recommended ascent rate: not exceeding 300-500 m per day when above 2500 m 4
- Slow ascent reduces acute mountain sickness incidence, which can reach 67% at altitudes above 4000 m with rapid ascent 2
Alternative Prophylactic Agents
Dexamethasone
- Dexamethasone 8-16 mg daily prevents acute mountain sickness with a number needed to treat of 2.8, showing no dose-responsiveness within this range 2
- Critical caveat: Abrupt discontinuation of dexamethasone can cause adverse reactions including depression (number needed to harm 3.7) 2
- Dexamethasone should be reserved for situations where acetazolamide is contraindicated or when rapid ascent is unavoidable 6
Important Clinical Considerations
Side Effects and Monitoring
- Acetazolamide commonly causes paresthesias (number needed to harm 3.0) and polyuria (number needed to harm 3.6) 2
- Concomitant administration of acetazolamide with other diuretics increases risk of dehydration and electrolyte imbalances and should be carefully evaluated 4
- In patients on chronic diuretics, administration should be based on balanced evaluation of dehydration versus fluid gain signs 4
Special Populations
Women
- Although higher vulnerability to acute mountain sickness in women has not been unambiguously demonstrated, sex-dependent physiological reactions to hypoxia may contribute to increased susceptibility in some women 4
- Adequate acclimatization, slow ascent, and/or preventive medication with acetazolamide are appropriate solutions 4
- Most publications do not find women at increased risk for acute mountain sickness, and general prevention strategies should be used regardless of sex 7
Cardiovascular Patients
- Patients should continue pre-existing cardiovascular medications at high altitude 4
- Acetazolamide use for acute mountain sickness prevention may be particularly helpful in ischemic patients, though specific data in coronary artery disease are lacking 4
- Selective beta-1 blockers (nebivolol) are preferred over non-selective beta-blockers (carvedilol) as they preserve exercise tolerance better at altitude 4
Risk Factors and Epidemiology
- Acute mountain sickness affects 25-85% of travelers to high altitudes depending on ascent rate, home altitude, and individual susceptibility 5
- Lower oxygen saturation and higher heart rate following high altitude exposure are associated with acute mountain sickness susceptibility 8
- Alcohol consumption appears to be a risk factor for acute mountain sickness 8
- The most common symptom is headache, followed by dyspnea, insomnia, dizziness, lassitude, and anorexia 8